Semaglutide (50 mg)
All products are 100% genuine and sourced from trusted manufacturers, with authenticity that can be verified for complete peace of mind.
Order exactly what you need with no minimum quantity required, whether it’s a single unit or a larger order.
Your order is guaranteed to arrive safely, with full shipment tracking and dedicated support to ensure a smooth delivery experience.
Your payments are protected with industry-standard encryption and trusted payment providers, ensuring every transaction is safe, private, and secure.
99% PURITY GUARANTEE
99% PURITY GUARANTEE
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC). Full analytical reports are available in the Certificate of Analysis section.
Preparation & Handling Notice
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
RESEARCH USE ONLY
This product is intended for research use only. It is not for human or veterinary use, not for diagnostic or therapeutic purposes, and should only be handled by qualified professionals.
Strength: 50 mg
CAS: 910463-68-2
Chemical Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular weight: 4113.6 g/mol
Peptide Sequence: H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-OH
Synonyms: NN9535
Storage: Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
Shelf life: 24 months from the manufacturing date.
Semaglutide is a synthetic GLP-1 receptor agonist analog supplied as a high-purity lyophilized peptide for laboratory research. It is widely studied in metabolic and endocrine research models to investigate glucose regulation, hormone signaling, and receptor-mediated cellular responses under controlled experimental conditions.
-
Cold chain shipping available for temperature-sensitive products.
-
Orders are processed within 1–2 business days.
-
Delivery timelines vary by destination and shipping method — view our Shipping Policy for region-specific estimates.
-
Tracking information will be provided once shipped.
-
No order minimum applies.
-
If your shipment is delayed, lost, or arrives damaged, you're covered under our Refund & Replacement Policy.
We accept Visa, Mastercard, and American Express. Apple Pay and Google Pay are available upon request via your account manager.
All transactions are processed through a secure, PCI DSS–compliant system to ensure your data is fully protected.
Why Choose NOVERA COMPOUNDS Peptides?
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
- High-purity, research-grade peptide synthesis
- Analytical testing to verify quality and composition
- Consistent batch-to-batch performance
- Batch identification on every vial for traceability
- Stored and shipped under controlled conditions
High-purity, research-grade peptide synthesis
Why Choose Medica Depot
Shop hundreds of medical products with no minimums and free shipping on large orders.
400+ products
No order minimums
Free shipping
Loyalty rewards
Trusted since 2007
Account manager
Verified LOT numbers
INFORMATION
What is Semaglutide (50 mg)?
Semaglutide (50 mg) is a synthetic peptide analog used in laboratory research to investigate metabolic regulation and related signaling activity in experimental systems. It is commonly used to explore how peptide-based compounds influence nutrient-response pathways, cellular communication, and downstream biological readouts in preclinical or in vitro models. With a defined sequence and high purity, it supports controlled study designs where material consistency and reproducibility are crucial.
Product Specifications
- CAS Number: 910463-68-2
- Peptide Sequence: H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-OH
- Category: Peptides
- Subcategory: Weight Loss & Metabolic Peptides
- Chemical Formula: C₁₈₇H₂₉₁N₄₅O₅₉
- Molecular Weight:6 g/mol
- Synonyms: NN9535
- Purity: ≥99% (99.88% typical)
- Packaging Format: 50 mg
- Storage Conditions: Store at -20°C, avoid light exposure
- Designation: For Laboratory Research Use Only
Key Characteristics of Semaglutide (50 mg)
- High Purity: ≥99% purity, designed for research environments where consistency is essential.
- Defined Peptide Sequence: Supports repeatable experimental setup and comparison across studies.
- Commonly Studied: Frequently used in metabolic research to evaluate peptide-driven signaling and regulation.
- Larger Packaging Format: Supplied in a 50 mg format for laboratories requiring a larger mass for project work or method development.
- Light- and Temperature-Sensitive: Store at -20°C and protect from light.
- Research Use Only: Not intended for diagnostic, therapeutic, or consumer applications.
How Semaglutide (50 mg) Supports Research
In research settings, Semaglutide is used to investigate metabolic regulation and peptide-related signaling. It is often included in studies examining how metabolic pathways respond to peptide-based compounds in controlled experimental systems. Researchers commonly use it to support projects focusing on energy balance biology, nutrient signaling, and metabolic model development, where a consistent, well-characterized peptide reagent is needed.
Research Applications & Usage Information
Semaglutide (50 mg) is commonly used as a research reagent in studies such as:
- Metabolic Signaling Studies: Exploring pathway activity and downstream cellular responses in experimental models.
- Glucose and Energy Regulation Research: Investigating how metabolic control systems respond to peptide-based tools.
- Appetite and Nutrient-Response Pathway Research: Focused on characterizing signaling networks in preclinical or in vitro models, rather than clinical outcomes.
- Receptor Interaction and Binding Characterization: Used in screening assays, comparative profiling, or method validation.
- Model Development and Benchmarking: Evaluating readouts, assay performance, or reproducibility using a standardized peptide reference material.
- Stability and Analytical Testing: Including identity confirmation, purity checks, and comparability testing in lab workflows.
Note: Research applications vary depending on laboratory protocol and model selection. This material is intended for laboratory research only.
Handling and Storage Recommendations
- Store at -20°C.
- Protect from light exposure by keeping the vial in its original packaging or a light-limiting container when not in use.
- Avoid repeated warming and freezing.
- Keep the container tightly closed and handle with standard laboratory precautions to reduce the risk of contamination.
- Label clearly for research use and store according to your lab’s chemical hygiene and inventory procedures.
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
- Lau J, Bloch P, Schäffer L, et al. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. J Med Chem. 2015;58(18):7370-7380. doi:10.1021/acs.jmedchem.5b00726
- Loomba R, Abdelmalek MF, Armstrong MJ, et al. Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2023;8(6):511-522. doi:10.1016/S2468-1253(23)00068-7
- Knudsen LB, Lau J. The Discovery and Development of Liraglutide and Semaglutide. Front Endocrinol (Lausanne). 2019;10:155. Published 2019 Apr 12. doi:10.3389/fendo.2019.00155
What is Semaglutide (50 mg)?
Semaglutide (50 mg) is a synthetic peptide analog used in laboratory research to investigate metabolic regulation and related signaling activity in experimental systems. It is commonly used to explore how peptide-based compounds influence nutrient-response pathways, cellular communication, and downstream biological readouts in preclinical or in vitro models. With a defined sequence and high purity, it supports controlled study designs where material consistency and reproducibility are crucial.
Product Specifications
- CAS Number: 910463-68-2
- Peptide Sequence: H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-OH
- Category: Peptides
- Subcategory: Weight Loss & Metabolic Peptides
- Chemical Formula: C₁₈₇H₂₉₁N₄₅O₅₉
- Molecular Weight:6 g/mol
- Synonyms: NN9535
- Purity: ≥99% (99.88% typical)
- Packaging Format: 50 mg
- Storage Conditions: Store at -20°C, avoid light exposure
- Designation: For Laboratory Research Use Only
Key Characteristics of Semaglutide (50 mg)
- High Purity: ≥99% purity, designed for research environments where consistency is essential.
- Defined Peptide Sequence: Supports repeatable experimental setup and comparison across studies.
- Commonly Studied: Frequently used in metabolic research to evaluate peptide-driven signaling and regulation.
- Larger Packaging Format: Supplied in a 50 mg format for laboratories requiring a larger mass for project work or method development.
- Light- and Temperature-Sensitive: Store at -20°C and protect from light.
- Research Use Only: Not intended for diagnostic, therapeutic, or consumer applications.
How Semaglutide (50 mg) Supports Research
In research settings, Semaglutide is used to investigate metabolic regulation and peptide-related signaling. It is often included in studies examining how metabolic pathways respond to peptide-based compounds in controlled experimental systems. Researchers commonly use it to support projects focusing on energy balance biology, nutrient signaling, and metabolic model development, where a consistent, well-characterized peptide reagent is needed.
Research Applications & Usage Information
Semaglutide (50 mg) is commonly used as a research reagent in studies such as:
- Metabolic Signaling Studies: Exploring pathway activity and downstream cellular responses in experimental models.
- Glucose and Energy Regulation Research: Investigating how metabolic control systems respond to peptide-based tools.
- Appetite and Nutrient-Response Pathway Research: Focused on characterizing signaling networks in preclinical or in vitro models, rather than clinical outcomes.
- Receptor Interaction and Binding Characterization: Used in screening assays, comparative profiling, or method validation.
- Model Development and Benchmarking: Evaluating readouts, assay performance, or reproducibility using a standardized peptide reference material.
- Stability and Analytical Testing: Including identity confirmation, purity checks, and comparability testing in lab workflows.
Note: Research applications vary depending on laboratory protocol and model selection. This material is intended for laboratory research only.
Handling and Storage Recommendations
- Store at -20°C.
- Protect from light exposure by keeping the vial in its original packaging or a light-limiting container when not in use.
- Avoid repeated warming and freezing.
- Keep the container tightly closed and handle with standard laboratory precautions to reduce the risk of contamination.
- Label clearly for research use and store according to your lab’s chemical hygiene and inventory procedures.
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
- Lau J, Bloch P, Schäffer L, et al. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. J Med Chem. 2015;58(18):7370-7380. doi:10.1021/acs.jmedchem.5b00726
- Loomba R, Abdelmalek MF, Armstrong MJ, et al. Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2023;8(6):511-522. doi:10.1016/S2468-1253(23)00068-7
- Knudsen LB, Lau J. The Discovery and Development of Liraglutide and Semaglutide. Front Endocrinol (Lausanne). 2019;10:155. Published 2019 Apr 12. doi:10.3389/fendo.2019.00155
Related products
